Cedars-Sinai scientists, in collaboration with expert colleagues around the globe, used stem cells to re-create Huntington’s Disease in a petri dish, allowing researchers for the first time to test potential treatments for the fatal inherited neurological disorder directly on human cells.
As outlined in a paper published online by Cell Stem Cell and slated for print in the journal’s Aug. 3 issue, scientists at Cedars-Sinai’s Regenerative Medicine Institute and the University of Wisconsin took skin cells from patients with Huntington’s disease and reprogrammed them into powerful stem cells; these were then made into the nervous system cells affected by the disease. Seven laboratories around the world collaborated to demonstrate the cells had hallmarks of Huntington’s.
“Now that we’ve moved from skin cells to brain cells, the next step forward will be to test treatments we can move from the petri dish to the clinic,” said Clive Svendsen, PhD, director of the Cedars-Sinai Regenerative Medicine Institute and a senior author of the study. “In addition to increasing our understanding of this disorder and offering a new pathway to identifying treatments, this study is remarkable because of the extensive interactions between a large group of scientists focused on developing this model. It’s a new way of doing trailblazing science.”
This breakthrough is the latest example of an innovative use for stem cells, reprogramming them to create laboratory versions of diseases. This method has been used to mimic Parkinson’s disease, Alzheimer’s disease, ALS and spinal muscular atrophy. As these diseases all occur in living neurons – that patients can’t part with – the disease-in-a-dish models offer scientists an opportunity they never had before: to study in human cells how a disease attacks the neurons and plot strategies for fighting it.
The Huntington’s Disease iPSC Consortium united some of the world’s top scientists working on this disease. Cedars-Sinai researchers took skin cells from a several Huntington’s patients, including a six-year-old with a severe juvenile form of the disease. They genetically reprogrammed these tissues into induced pluripotent stem cells, which can be made into any type of cell in the body. The cells lines were banked by scientists at Cedars-Sinai and scrutinized by all consortium members for differences that may have led to the disease. These cell lines are now an important resource for Huntington’s researchers and have been made available via a National Institutes of Health-funded repository at Coriell Institute for Medical Research in New Jersey.
Huntington’s, known to the public, for example, as the cause of folksinger Woody Guthrie’s death, typically strikes patients in midlife. It causes jerky, twitching motions, loss of muscle control, psychiatric disorders and dementia; the disease ultimately is fatal. In rare, severe cases, the disorder appears in childhood.
Researchers believe that Huntington’s results from a mutation in the huntintin gene, leading to production of an abnormal protein and ultimately cell death in specific areas of the brain that control movement and cognition. There is no cure for Huntington’s, nor therapies to slow its progression.
The consortium showed Huntington’s cell deficits or how they differ from normal cells, including that they were less likely to survive cultivation in the petri dish. Scientists tried depriving them of a growth factor present around normal cells, or “stressing” them, and found that Huntington’s neurons died even faster. The trick with disease-in-a-dish models is verifying that the cells are, in fact, behaving in the same manner they would in a patient, said Virginia Mattis, a post-doctoral scientist at the Cedars-Sinai Regenerative Medicine Institute and one of the lead authors of the study.
“It was great that these characteristics were seen not only in our laboratory, but by all of the consortium members using different techniques,” Mattis said. “It was very reassuring and significantly strengthens the value of this study.”
This new model will provide the foundation for a new round of experiments by the consortium funded by a new grant from the NIH and the California Institute for Regenerative Medicine.
The Cedars-Sinai’s Regenerative Medicine Institute has made a major commitment to projects like this Huntington’s study in which stem cell research helps to advance understanding of human disease and open new and innovative methods to identify treatments and cures. The institute has developed an induced pluripotent stem cell core facility and recruited faculty to work in this emerging area of regenerative medicine research.
“At last, we have a human cell model for this tragic disease that will be a powerful new tool in identifying treatments for these patients,” said Shlomo Melmed, MD, dean of the medical faculty at Cedars-Sinai and the Helena A. and Philip E. Hixon Chair in Investigative Medicine. “This development is a compelling example of how important iPS cells are to furthering our understanding and finding cures for diseases that are currently untreatable.”
The consortium includes: Cedars-Sinai Medical Center; Johns Hopkins University School of Medicine in Baltimore; University of California, Irvine; University of Wisconsin School of Medicine; Massachusetts General Hospital; Harvard Medical School; University of California, San Francisco; Cardiff University; Universita degli Studi di Milano; and the CHDI Foundation.
Funding for the research came from an American Recovery and Reinvestment Act grant from the NIH’s National Institute of Neurological Disorders and Stroke (NINDS Recovery Act grant number: RC2-NS069422 ), a grant from the CHDI Foundation, Inc. and CIRM.
Nicole White | Cedars-Sinai News
Further reports about: > Cedars-Sinai > Huntington’s > Huntington’s Disease > Mattis > Medical Wellness > Medicine > Regenerative Therapien > brain cell > cell death > human cell > induced pluripotent stem > induced pluripotent stem cell > normal cells > pluripotent stem > psychiatric disorder > skin cell > stem cells
Zebrafish's near 360 degree UV-vision knocks stripes off Google Street View
22.06.2018 | University of Sussex
New cellular pathway helps explain how inflammation leads to artery disease
22.06.2018 | Cedars-Sinai Medical Center
In a recent publication in the renowned journal Optica, scientists of Leibniz-Institute of Photonic Technology (Leibniz IPHT) in Jena showed that they can accurately control the optical properties of liquid-core fiber lasers and therefore their spectral band width by temperature and pressure tuning.
Already last year, the researchers provided experimental proof of a new dynamic of hybrid solitons– temporally and spectrally stationary light waves resulting...
Scientists from the University of Freiburg and the University of Basel identified a master regulator for bone regeneration. Prasad Shastri, Professor of...
Moving into its fourth decade, AchemAsia is setting out for new horizons: The International Expo and Innovation Forum for Sustainable Chemical Production will take place from 21-23 May 2019 in Shanghai, China. With an updated event profile, the eleventh edition focusses on topics that are especially relevant for the Chinese process industry, putting a strong emphasis on sustainability and innovation.
Founded in 1989 as a spin-off of ACHEMA to cater to the needs of China’s then developing industry, AchemAsia has since grown into a platform where the latest...
The BMBF-funded OWICELLS project was successfully completed with a final presentation at the BMW plant in Munich. The presentation demonstrated a Li-Fi communication with a mobile robot, while the robot carried out usual production processes (welding, moving and testing parts) in a 5x5m² production cell. The robust, optical wireless transmission is based on spatial diversity; in other words, data is sent and received simultaneously by several LEDs and several photodiodes. The system can transmit data at more than 100 Mbit/s and five milliseconds latency.
Modern production technologies in the automobile industry must become more flexible in order to fulfil individual customer requirements.
An international team of scientists has discovered a new way to transfer image information through multimodal fibers with almost no distortion - even if the fiber is bent. The results of the study, to which scientist from the Leibniz-Institute of Photonic Technology Jena (Leibniz IPHT) contributed, were published on 6thJune in the highly-cited journal Physical Review Letters.
Endoscopes allow doctors to see into a patient’s body like through a keyhole. Typically, the images are transmitted via a bundle of several hundreds of optical...
13.06.2018 | Event News
08.06.2018 | Event News
05.06.2018 | Event News
22.06.2018 | Materials Sciences
22.06.2018 | Earth Sciences
22.06.2018 | Life Sciences